These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8707343)
1. Expression and function of membrane regulators of complement on rat astrocytes in culture. Rogers CA; Gasque P; Piddlesden SJ; Okada N; Holers VM; Morgan BP Immunology; 1996 May; 88(1):153-61. PubMed ID: 8707343 [TBL] [Abstract][Full Text] [Related]
2. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244 [TBL] [Abstract][Full Text] [Related]
3. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Gasque P; Morgan BP Immunology; 1996 Nov; 89(3):338-47. PubMed ID: 8958045 [TBL] [Abstract][Full Text] [Related]
4. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells. van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227 [TBL] [Abstract][Full Text] [Related]
5. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues. Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613 [TBL] [Abstract][Full Text] [Related]
6. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity. Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980 [TBL] [Abstract][Full Text] [Related]
7. Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis. Bardenstein DS; Cheyer CJ; Lee C; Cocuzzi E; Mizuno M; Okada N; Medof ME Immunology; 2001 Dec; 104(4):423-30. PubMed ID: 11899428 [TBL] [Abstract][Full Text] [Related]
8. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965 [TBL] [Abstract][Full Text] [Related]
9. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. Gasque P; Thomas A; Fontaine M; Morgan BP J Neuroimmunol; 1996 May; 66(1-2):29-40. PubMed ID: 8964911 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line. Harris CL; Morgan BP Immunology; 1995 Oct; 86(2):311-8. PubMed ID: 7490134 [TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in rat CD59 that increase the complement regulatory activity. Hinchliffe SJ; Morgan BP Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333 [TBL] [Abstract][Full Text] [Related]
12. Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Rushmere NK; Tomlinson S; Morgan BP Immunology; 1997 Apr; 90(4):640-6. PubMed ID: 9176120 [TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. Qian YM; Qin X; Miwa T; Sun X; Halperin JA; Song WC J Immunol; 2000 Sep; 165(5):2528-34. PubMed ID: 10946279 [TBL] [Abstract][Full Text] [Related]
14. Effects of complement activation on the expression of CD59 by human mesangial cells. Shibata T; Kohsaka T J Immunol; 1995 Jul; 155(1):403-9. PubMed ID: 7541422 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Simpson KL; Holmes CH Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850 [TBL] [Abstract][Full Text] [Related]
17. Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function. Zhou Q; Zhao J; Hüsler T; Sims PJ Mol Immunol; 1996 Oct; 33(14):1127-34. PubMed ID: 9047379 [TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of complement regulatory membrane proteins in rats. Funabashi K; Okada N; Matsuo S; Yamamoto T; Morgan BP; Okada H Immunology; 1994 Mar; 81(3):444-51. PubMed ID: 7515849 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. Singhrao SK; Neal JW; Rushmere NK; Morgan BP; Gasque P Am J Pathol; 2000 Sep; 157(3):905-18. PubMed ID: 10980130 [TBL] [Abstract][Full Text] [Related]
20. CD59 protects rat kidney from complement mediated injury in collaboration with crry. Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]